Life Sciences
Clinical trial delays are easier to fix when you see them early
Site activation delays, slow enrollment, and patient dropout often leave early signs in the data. Each week, we turn those signs into a short report with ranked next steps, so your team can act before delays add up.
Clinical trial problems PING solves

Site Activation
Sites are slow to activate, and the delay cascades into enrollment.
Each week, we review activation dates across your sites and flag the ones falling behind. You get suggested steps to speed them up before enrollment targets slip.

Enrollment Velocity
Enrollment is behind target, but the team finds out too late.
Each week, we compare each site's enrollment with your plan. When a site starts to drift, we flag it early enough to fix, not after the window has closed.

Patient Engagement
Patients are enrolled but not engaging, and no one notices until they discontinue.
Where your data allows, we look for early warning signs between visits, such as missed contacts or late visits. When a pattern changes, we flag it so your team can reach out before a participant leaves.

Intervention Impact
Interventions happen, but no one knows
if they worked.
We track every step we suggest. If a site gets extra recruitment support, we check whether its enrollment actually improved and show the result in the next weekly report.
Who PING Serves
Built for clinical research teams of every scale
Pharmaceutical Companies
Multi-trial portfolio monitoring across global sites.
Biotech
Focused trial monitoring with lean operations.
Contract Research Organizations
Client trial monitoring and cross-study performance tracking.
Academic Research
Investigator-initiated trial monitoring with limited resources.
Ready to see your trial's risks before they slip?
Everything you need to know
Each week, we review activation dates across your sites and flag the ones falling behind. We suggest steps to speed them up before enrollment targets slip.
Each week, we compare each site's enrollment with your plan. A site that starts to drift is flagged while there's still time to correct course.
Not every dropout can be predicted. Where your data allows, we flag early warning signs, such as missed contacts or late visits, so your team can reach out before a participant decides to leave.
We track every step we suggest. If a site gets extra recruitment support, your next weekly report shows whether its enrollment actually improved.
All three, plus academic research — from multi-trial pharma portfolios to lean biotech teams, CRO client studies, and investigator-initiated trials.
Pricing is scoped to each study and measured against what a delayed trial costs. You get the price in writing before you commit.
Let's talk about your study
Tell us a little about your study and what you need. We'll reply by email with a clear next step. You can also write to us at hello@mastertable.com. Please don't send patient data through this form.





